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Myocardial infarctionHaving ischemic heart disease and myocardial infarctions in Indians
in their thirties and forties is unfortunately quite common. The exact
cause remains unknown and therefore somany theories have been pro-
posed regarding the aetiopathogenesis of this disease in Indians. Re-
cently an Indian man presented in my ofﬁce with angina without any
known coronary risk factors requiring cardiac testing, medical therapy
and coronary stenting.
A man of Indian origin came to my ofﬁce for evaluation of his exer-
tional chest discomfort for 2–3 weeks before presentation (lawn mow-
ing and working in a motel). He has otherwise been physically active
and these symptoms were new and concerning to him. His blood pres-
sure in the ofﬁce was 130/80 with the heart rate of 80 per minute. His
height was 5′10″ with a BMI of 23.5. His baseline ECG was
unremarkable.
Hewalked on the treadmill inmyofﬁce for 6min and 40 swithwork
load achieved: 7.2 METS. He developed the chest tightness and some
upsloping ST depressions in inferolateral leads. The test was
discontinued at patient's request. During recovery phase he showed
horizontal 1.5mmST depression in the ECG leads. Hewas placed on As-
pirin, a beta blocker, a statin and because of his classic symptoms of an-
gina and him being a high risk patient (being Indian), he was requested
to undergo diagnostic coronary angiographywhich revealed: a long 95%
proximal left anterior artery disease (LAD). He underwent coronary an-
gioplasty and stenting of proximal LAD. Mid-RCA has about 40% disease
and would be managed medically. Right before diagnostic coronary an-
giography, his CBC, electrolytes, renal and liver function were normal
and the lipid proﬁle showed: Total cholesterol: 102, triglycerides: 48,
LDL: 49 and HDL: 44 mg/dl.
2 weeks after his coronary intervention, his BP was 120/72, follow
up ECG was unremarkable and he remains asymptomatic. Being physi-
cally very active, he decided not go for cardiac rehabilitation program.
Notmuchwork has beendone on coronary artery disease in India ei-
ther by the government bodies, research organizations or private sec-
tors. Most of the work has been in the form of observational data,
statewide local prevalence studies, case reports etc. and there is not
much work reported on this condition in people of southeast Indian or-
igin in the west either. Health care providers apply mostly the US and
European guidelines while taking care of these patients.
Using the traditional/conventional cardiac risk factors, he did not
have history of hypertension. His BP at the time of presentation washttp://dx.doi.org/10.1016/j.ctrsc.2016.08.002
2405-5875/© 2016 The Authors. Published by Elsevier B.V. This is an open access article under130/80 and he was not taking any anti-hypertensive medications. He
is a non-smoker and no history of any drug abuse. He did not have dia-
betes. He did not give history of premature CAD in the family. He has
been physically quite active and he was not overweight or obese
(weight 160 lb). His body mass index was: 23.5.
As a matter of fact, his very ﬁrst question after he came back for fol-
low up was: “If my lipid proﬁle was so good, how come, I had a 95%
blockage in one of the coronary arteries?” His second question was: “If
lipid proﬁle is such before the intervention, Doc, how low should I
bring down my total cholesterol and LDL?” I am not sure if I have the
right scientiﬁc answers to these questions.
Asian Indians are ethnically more prone to develop cardiovascular
diseases (CVD). Studies in migrant South Indians living in UK, South Af-
rica, Singapore and North America show higher prevalence and 2–4
times higher mortality from CVD than the native populations [1–3].
Coronary heart disease (CHD) in Indians has been shown to be pre-
mature occurring at an early age and is much more aggressive, exten-
sive and malignant. 52.2% of deaths due to CVD occur before the age
of 70 years of age in India as compared with only 22.8% in theWest [4].
A study called, SHARE has clearly demonstrated that there is about
4.5 times higher chances for Indians to develop CHD compared to Euro-
peans after adjusting for the conventional and novel risk factors [3]. In
addition, that study also showed that the Indians carry higher levels of
pro-thrombotic factors (lipoprotein (a), ﬁbrinogen, and plasminogen
activator inhibitor-1) and have less levels of tissue plasminogen activa-
tor. These issues aremuchmore important in Indians than others. These
parameters were not investigated in our case at the time of ﬁrst presen-
tation, however on subsequent followup lab tests, thesewill be request-
ed to be carried out.
Conventional/traditional cardiac risk factors explain only half of the
cases and surprisingly 30–50% cases lack these risk factors altogether,
more so in Indians. However, in general one issue is very clear and
disturbing that 15% urban and overseas Indians develop Diabetes as
compared to 4% in North Americans and Europeans. Moreover, Indians
also have increased chances of developing Insulin resistance syndrome
which is characterized by hyperinsulinemia, insulin resistance, non-in-
sulin dependent diabetes, hypertension, central obesity and a unique
dyslipidemia (high triglycerides and low HDL) [5]. Time and again, var-
ious studies have shown that the risk of myocardial infarction is about 4
times higher in diabetics compared to non-diabetics. A study from south
India as clearly demonstrated that as the blood sugar levels rose, so did
the prevalence of CHD. In that study, CAD prevalence was noted to be
9.1% in people with normal blood sugar levels, 14.9% in those with im-
paired glucose tolerance and 21.4% in those with obvious diabetes [6].
Our present patient did not have diabetes.
Indian population is known to show a different kind of dyslipidemia,
something found in individuals with insulin resistance syndrome like
low HDL, high triglycerides, and high total cholesterol to HDL ratio [7].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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LDLwas 49mg/dl and triglyceride level was 48mg/dl prior to any statin
therapy. The question arises: how low can I bring his LDL? At what level
of his LDL, should I be satisﬁed?
There is also strong evidence that the obesity in Indians is unique,
more central obesity with higher waist-hip ratio and higher body fat
at any given level of body-mass index (BMI). This might mean that
BMImay not truly reﬂect obesity in Indians [8–9] and other parameters
should be sought including possibly using BMI of 23 as opposed to 25 as
a marker of beginning of obesity. BMI in our patient was 23.5 which is
way better than for the most Indian and the western patients.
Will novel cardiac risk factors explain the excess risk of CHD in In-
dians in general and in our present case, in particular? Prothrombotic
factors like elevated lipoproteins (a) are amongst them. Lipoprotein
(Lp) (a) is about 2 times higher in Indians compared to the Caucasians
and these could possibly explain the excess cardiac risk in Indians
[10–12]. It is considered that some Indians are uniquely predisposed
to excessive CHD risk based on the genetics and the elevated levels of
Lp (a) could be one of its mechanism of genetic operation [13]. Lp (a)
is more thrombogenic (by increasing PAI-1 activity) and 5 times more
atherosclerotic than LDL [14].
It is not right place to discuss the implications of these ﬁndings for
the Indian population in general. However, I would like to brieﬂy men-
tion that it has been predicted that the individuals with Indian ethnicity
would account for 40–60% of global CVD burden within the next 10–
15 years [15]. Over the last 30 years the risk of CHD has increased
from 2% to 6% in rural population and from 4% to 12% in urban popula-
tion in India [16].
Based on the description so far as noted above, south Asian Indians
have been noted to have a unique phenotype described by combination
of clinical (larger waist-hip ratios, larger waist-height ratios indicating
excessive visceral adiposity), biochemical (insulin resistance, lower
adiponectin and higher C-reactive protein), and metabolic aberrations
(increased triglycerides, low HDL) [17].
I must include here some ﬁndings from the study, INTERHEART
pertinent to our discussion [18]:
1. Death due to acutemyocardial infarction (AMI) in south Asians occur
5–10 years earlier than the western population.
2. South Asian men encountering AMI were 5.6 years younger than
women.
3. The higher risk of AMI in their younger age is largely determined by
the higher levels of risk factors and the nine conventional risk factors
(abnormal lipids, smoking, hypertension, diabetes, abdominal obesi-
ty, psychosocial factors, consumption of fruits and vegetables, alcohol
and regular physical activity) collectively explains 86% of the AMI
risk in south Asians.
4. Abnormal Apo-B/ApoA-1 ratio and smoking are the most important
risk factors.
5. Low education level is associated with higher level of AMI
worldwide.
6. South Asians have signiﬁcantly higher level of Waist-hip ratio
attributing to higher visceral adiposity.
7. Regular consumption of alcohol is not protective for AMI in south
Asians.
Post-intervention follow up
Threemonths after his coronary intervention, he was brought to the
ofﬁce for follow up. I was concerned him having an excellent lipid pro-
ﬁle and lack of most traditional cardiac risk factors and therefore I
wanted to see what else I could do study his disease further and help
prevent him having future cardiac events. He was in Atorvastatin
40 mg, Aspirin, Brilinta, and Metoprolol.
At this point, I had requested follow up lipid proﬁle, along with ho-
mocysteine and lipoprotein (a) levels: Total cholesterol: 100 mg/dl(unchanged), TG: 62, LDL: 38 mg/dl (much lower) and HDL: 50 mg/dl.
CRP level: normal range. Lipoprotein (a): 346 nmol/L (normal less
than 75).
This markedly elevated lipoprotein (a) could very well be the most
signiﬁcant risk/causation of atherosclerosis in his case. There is not
much known to lower this lipoprotein (a) levels. The literature reports
some successwith Aspirin, Atorvastatin, Niaspan, ﬁsh oil for vegetarians
and possibly some role of alcohol. All these issues were discussed with
him. Aspirin was increased to 325 mg a day, and Niaspan was added.
Family screening for lipoprotein (a) was encouraged. Follow up is
being arranged in threemonths after all these interventions are in place.
My patient, a 51 year old man of Indian origin who is a non-smoker,
non-diabetic, non-hypertensive with an excellent lipid proﬁle without
any history of premature CAD in the family presentedwith 2weeks his-
tory of angina and was found to have 95% proximal LAD disease which
was treated appropriately and 40% mid-RCA disease.
Among so many questions, the more pertinent ones are:
1. Why did he develop a symptomatic CAD at such an early age in the
absence of any known traditional cardiac risk factors?
2. What can he do otherwise so that he does not develop same disease
again?Hewas already exercising andhe is not overweight andhedid
not otherwise require any medications for any known risk factors!
3. How dowe prognosticate patients like this, in terms of future cardiac
events?
4. Based onmyexperiencewith this patient, howdo I apply that knowl-
edge to my other patients of Indian origin?
A. Do I ask them to have lipid proﬁle to be tested atmuch earlier age?
B. Do I request to keep their LDL below70mg/dl in the absence of any
known CAD and below 50 mg/dl if they have a known CAD?
C. And/or should I put every patient of Indian origin on a statin irre-
spective of their lipid proﬁle?
D. Should all patients of South East Asian/Indian origin have their li-
poprotein (a) levels checked at the time of their ﬁrst lipid proﬁle
evaluation?
To have answer to all these questions and many more, Indian
physicians and Government of India along with the West will have to
undertake extensive research in India and abroad in terms of genetics,
prevalence, risk factors, diets, exercise, yoga, statins, and newer
approaches.
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